سوق الصيدلة المتخصصة في كندا – اتجاهات الصناعة والتوقعات حتى عام 2030

تحليل وحجم سوق الصيدليات المتخصصة في كندا

يهدف نموذج الصيدلية المتخصصة إلى توفير نموذج شامل ومنسق للرعاية للمرضى المصابين بأمراض مزمنة وحالات طبية معقدة، وتحقيق نتائج سريرية واقتصادية متفوقة، وتسريع وصول المرضى إلى الرعاية. تربط الصيدليات المتخصصة المرضى المصابين بأمراض خطيرة بالأدوية الموصوفة لحالاتهم، وتوفر خدمات رعاية المرضى المطلوبة لهذه الأدوية، وتدعم المرضى الذين يواجهون تحديات في استرداد ثمن هذه الأدوية التي تغير حياتهم وفي بعض الأحيان تنقذ حياتهم ولكنها باهظة الثمن في كثير من الأحيان.

من المتوقع أن يؤدي ارتفاع عدد كبار السن إلى دفع نمو القطاع. ومع ذلك، من المتوقع أن يعيق الإطار التنظيمي الصارم نمو سوق الصيدلة المتخصصة في كندا.

تشير تحليلات Data Bridge Market Research إلى أن سوق الصيدليات المتخصصة في كندا من المتوقع أن تصل قيمته إلى 14,192.50 مليون دولار أمريكي بحلول عام 2030، بمعدل نمو سنوي مركب قدره 11.3% خلال الفترة المتوقعة. تشكل الخدمات السريرية أكبر شريحة في سوق الصيدليات المتخصصة في كندا.

Market Definition

Specialty pharmacies differ from traditional pharmacies in that they coordinate many aspects of patient care and disease management. They are intended to deliver medications with special handling, storage, and distribution requirements in a standardized manner that allows for economies of scale. Specialty pharmacies are also intended to improve clinical and economic outcomes for patients suffering from complex, often chronic, and rare conditions, with close contact and management by clinicians. Specialty pharmacies employ healthcare professionals who educate patients, help ensure appropriate medication use, promote adherence, and try to avoid unnecessary costs. Other support systems coordinate information sharing among clinicians treating patients and assist patients in locating resources to help with out-of-pocket expenses.

Canada Specialty Pharmacy Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:

Drivers/Opportunities

• Increasing prevalence of chronic and rare diseases

With the rising economic growth, people are more interested in long-term health and wellness. Patients with chronic diseases need to monitor their health on a regular basis. Specialty pharmacy services help manage chronic and rare diseases due to the availability of specialty drugs for chronic diseases such as diabetes, heart failure or chronic obstructive pulmonary disease (COPD), cancer, and rare diseases such as autoimmune disorders, namely eosinophilic granulomatosis with polyangiitis (EGPA), Guillain-Barre syndrome, Kawasaki disease among others. Its service includes medication dispensing and providing other healthcare assistance.

• Increasing geriatric population

As the geriatric population is more prone to chronic disease and injuries, the prevalence rate of their diseases and injuries in Canada leads to demand for specialty pharmacy services to monitor and care for their health. Therefore, the geriatric population and its rising disease rates play a major role in driving the specialty pharmacy market. These services use a unique combination of digital tools and compassionate clinical services to deliver fertility medication, nurse-administered home infusions, and care for people living with everything from rheumatoid arthritis, cancer, and HIV to the rarest of rare conditions.

• Emerging markets of specialty pharmacies

A major factor in the growth of the specialized pharmacy market is the aging population. Diabetes due to an unhealthy lifestyle and rising dementia, Alzheimer's, and Parkinson's diseases are common in the geriatric population. From 2015 to 2021, the number of seniors is projected to exceed the number of children aged 14 and younger for the first time. By 2036, seniors could reach between 9.9 and 10.9 million people. According to a medium-growth scenario, the number of people aged 80 and older is expected to double to 3.3 million by 2036. The population aged 100 and older could triple to more than 20,000. Apart from the geriatric population, GDP, population density, and improving access to the specialized pharmacy market create growth opportunities.

Restraints/Challenges

• Stringent regulatory framework

Canada's federal and provincial governments jointly set their pharmaceutical policy. The federal government is in charge of protecting producers' intellectual property rights (patents), initial approval, labelling, and overall market competition for prescription medications. The provincial government is in charge of and has authority over financing all medical services, including prescription drugs. Moreover, specialty drugs come under high-risk drugs, including those for chronic diseases such as cancer and rare diseases such as autoimmune diseases. Therefore, there are different sets of regulatory frameworks for the distribution as well as manufacturing of these drugs.

• Insufficient funding for specialty pharmacies

The mortality ratio due to chronic diseases is very high in the Canadian region. One of the major reasons for this is the insufficient funding for specialty pharmacies which leads to a decrease in the number of specialty pharmacies.

Specialty pharmacies deal with specialty drugs for chronic diseases and rare diseases. A specialty pharmacy is a state-licensed pharmacy that solely or largely provides medications for people with serious health conditions requiring complex therapies. These medications and therapies have very out-of-pocket rates, which in turn makes the specialty pharmacy a very costly business to start with, which requires huge amounts of investments and funding. The negligent government aid and initiatives are leading to the decline of these pharmacies.

Thus, the insufficient funding for specialty pharmacies may act as a challenge in the growth of Canada specialty pharmacy market.

Post COVID-19 Impact on Canada Specialty Pharmacy Market

The coronavirus pandemic has affected Canada's specialty pharmacy industry across four main areas: product sourcing and procurement, product launch and distribution, acquisition and access, and treatment and care management. Specialty pharmacies have risen to the occasion by working closely with federal and provincial government agencies to address challenges experienced by the healthcare system to combat the COVID-19 pandemic. These include exploring new ways of working, increasing testing capacity and results tracking for COVID-19, and ultimately working toward the development, manufacture, and delivery of safe and effective vaccines and treatment. Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple strategies and programs for the specialty pharmacy market.

Recent Development

• In March 2022, BioScript solutions and NeonMind announced the strategic partnership to expand the specialty clinic network for interventional psychiatry treatments. This partnership will leverage the BioScript solutions in an extensive national network of community-based infusion clinics to expand access to NeonMind's interventional psychiatry and unique treatment programs for Canadians

Canada Specialty Pharmacy Market Scope

Canada specialty pharmacy market is categorized into three segments, which are based on service type, type, and condition. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

• Service Type
  • Clinical services
  • Operational services
  • Other services

On the basis of service type, the Canada specialty pharmacy market is segmented into clinical services, operational services, and other services.

•  Type
  • Large pharmacy benefit manager (PBM)
  • Small-independent pharmacy service providers

On the basis of type, the Canada specialty pharmacy market has been segmented into large pharmacy benefit manager (PBM) and small-independent pharmacy service providers.

• Condition
  • Anemia
  • Cancer
  • HIV
  • Infertility
  • Multiple sclerosis
  • Rheumatoid arthritis
  • Growth hormone deficiencies
  • Hepatitis c virus
  • Hemophilia
  • Psoriasis
  • Pulmonary hypertension
  • Crohn's disease
  • Cystic fibrosis
  • Immune deficiency
  • Osteoarthritis
  • Juvenile idiopathic arthritis
  • Ulcerative colitis
  • Others

On the basis of condition, the Canada specialty pharmacy market has been segmented into anemia, cancer, HIV, infertility, multiple sclerosis, rheumatoid arthritis, growth hormone deficiencies, hepatitis C virus, hemophilia, psoriasis, pulmonary hypertension, Crohn's disease, cystic fibrosis, immune deficiency, osteoarthritis, juvenile idiopathic arthritis, ulcerative colitis, and others.

تحليل/رؤى إقليمية لسوق الصيدليات المتخصصة في كندا

يتم تحليل سوق الصيدليات المتخصصة في كندا، ويتم توفير رؤى حجم السوق والاتجاهات حسب البلد ونوع الخدمة والنوع والظروف كما هو مذكور أعلاه.

يشهد سوق الصيدليات المتخصصة في كندا نموًا بسبب الطلب المتزايد على الأدوية المتخصصة، ومن المتوقع أن يؤدي زيادة قنوات التوزيع بالإضافة إلى انتشار الأمراض المزمنة المتزايدة إلى دفع نمو السوق.

كما يوفر قسم الدولة في التقرير عوامل فردية مؤثرة على السوق والتغيرات في تنظيم السوق التي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. نقاط البيانات مثل تحليل سلسلة القيمة المصب والمصب، والاتجاهات الفنية وتحليل قوى بورتر الخمس، ودراسات الحالة هي بعض المؤشرات المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. كما يتم النظر في وجود وتوافر العلامات التجارية العالمية والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية، وتأثير التعريفات الجمركية المحلية، وطرق التجارة أثناء تقديم تحليل توقعات لبيانات الدولة.

تحليل المشهد التنافسي وحصة سوق الصيدلة المتخصصة في كندا

يوفر المشهد التنافسي لسوق الصيدليات المتخصصة في كندا تفاصيل حسب المنافس. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، والحضور العالمي، ومواقع الإنتاج والمرافق، والقدرات الإنتاجية، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق. تتعلق نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات على سوق الصيدليات المتخصصة.

بعض اللاعبين الرئيسيين الذين يعملون في سوق الصيدلة المتخصصة هم McKesson Canada و Bayshore HealthCare و SRx Health و Sentrex Health Solutions و Sobeys Inc. و PHARMASAVE و Lovell Drugs و Create Compounding Ltd. و Dynasty Pharmacy و Resident Care Pharmacy و Pace Pharmacy و Northmount Pharmacy و Compounding Lab و Medicine Centre و riverviewguardian.ca و Brunskillpharmacy و Extend Pharmacy و Sherman Specialty Pharmacy و Quiick Medicine و Allcures Pharmacy و Alpine Drug Mart IDA و PharmaChoiceAnchor Compounding Pharmacy و Andreen's Pharmacy و Balanced Health Integrative Pharmacy و Bains Pharmacy و Shoppers Drug Mart Specialty Health Network Inc. و MEDS وغيرها.

SKU-69504